NeuroCycle Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
NeuroCycle Therapeutics is a biotechnology research company focused on discovering and developing therapies that act within the central nervous system to address serious inflammatory and neurological disorders. It is based in Cambridge, Massachusetts, and originated as a spin-off linked to ETH Zurich, with roots dating to 2016. The company operates with a small team within the biotechnology research sector. In August 2021, Engrail Therapeutics acquired NeuroCycle Therapeutics, a significant corporate development tied to its ETH Zurich origin. The organization’s work centers on therapeutics aimed at CNS targets to treat inflammatory and neurological conditions.